SRF617, a Potent Enzymatic Inhibitor of CD39, Demonstrates Single-Agent Activity and Cooperates with Various Cancer Therapies in Both Solid Tumor and Hematologic Malignancies
Immunology(2020)
Key words
Extracellular ATP
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined